Matt Galsky
MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai

Dr. Galsky is Professor of Medicine (Hematology and Medical Oncology), Director of Genitourinary Medical Oncology, Co-Director of the Center of Excellence for Bladder Cancer at The Tisch Cancer Institute, and Associate Director for Translational Research at The Tisch Cancer Institute. Dr. Galsky specializes in the care of patients with genitourinary malignancies—bladder, prostate, kidney, and testicular cancers. His research centers on team science-based approaches to dissecting the mechanistic underpinnings of response and resistance to novel bladder cancer therapies.

Sessions

Register
General Session

Selected Topic in Genitourinary Cancer

Saturday, September 26, 2026
1:30 PM - 2:15 PM
General Session

First-Line Strategies in Metastatic Renal Cancer: Doublet Immune Checkpoint Blockade vs Immune Checkpoint Blockade Plus VEGFR TKI

Saturday, September 26, 2026
3:30 PM - 4:15 PM
General Session

Optimizing Immunotherapy Strategies in Muscle-Invasive Bladder Cancer: Neoadjuvant IO-Containing Systemic Therapy vs Risk-Adapted Adjuvant IO

Sunday, September 27, 2026
1:30 PM - 2:15 PM
General Session

Using Lutetium-PSMA in Metastatic Prostate Cancer: Early vs Later Use

Sunday, September 27, 2026
3:30 PM - 4:15 PM
Back to top